This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Pooh-Poohing Private Equity

Go Soros One Better

"Everyone wants to invest like George Soros," Cramer told his viewers. At least, that's what he gathers from the fact that the George Soros portfolio is's most popular.

But Cramer said he doesn't want to invest like Soros. "I want to be better than Soros!" he said.

For example, Soros owns Bon-Ton (BONT - Get Report), but Cramer wouldn't, because it's "too dicey. ... Maybe it's a long-term Soros pick, because short term it really stinks."

Soros also owns CVS (CVS - Get Report), which Cramer said he likes after its great Caremark deal, "but I have preferred over and over again Rite Aid (RAD - Get Report)."

And Soros own Qualcomm (QCOM - Get Report), but Cramer prefers Texas Instruments (TXN - Get Report).

The one Soros stock that Cramer said he really thinks people should be in is diagnostics company Gen-Probe (GPRO).

"On 'Mad Money,'" he said, "we're delighted by diagnostics." He owns two diagnostics companies -- Inverness Medical Innovations (IMA) and Hologic (HOLX - Get Report) -- for his charitable trust, Action Alerts PLUS .

As for Gen-Probe, Cramer said it is "instant growth."

It is one of the two major providers of blood-screening tests, with 40% of market share. It also is in an "enviable position with 58% of the market for chlamydia and gonorrhea tests."

In addition, the company has its future all worked out, with alliances with General Electric (GE), 3M (MMM) and Millipore (MIL).

"Don't invest like George Soros," Cramer said. "Invest better than George Soros. Go buy some Gen-Probe."

Mad Mail

In his "Mad Mail" segment, Cramer agreed with one viewer that Manitowoc (MTW) is "absolutely" a stock that should be considered for Cramer's $80-to-$120 theory.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs